NeuroFlow key facts
- Developer of behavioral health integration technology designed to support coordinated care and informed decision-making in healthcare organizations.
- NeuroFlow’s last known valuation is $307.0M.
- It has raised $122.3M across 5 recorded rounds; the latest was Early Stage VC ($25.5M) in Jul 2022.
- Notable investors include Alumni Ventures, US National Science Foundation, MedTech Innovator, GV, F-Prime Capital — 45 tracked in total.
- NeuroFlow has filed 5 Form Ds with the SEC since 2017, most recently Oct 2022 ($25.5M sold to 19 investors).
- Status: Privately Held (backing).
Who backs NeuroFlow
45+- ·The complete investor list: 45 names
- ·Watch NeuroFlow: the Monday email on marks, rounds and moves
NeuroFlow funding rounds
5 roundsNeuroFlow valuation
NeuroFlow's last known valuation is $307 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has NeuroFlow raised?
NeuroFlow has raised $122 million in total; 5 of its rounds are on record, from 2017 on. The largest on record was a $906,250 seed round in Aug 2017; the most recent was a $25.5 million early-stage round in Jul 2022.
NeuroFlow has filed 5 Form Ds with the SEC since 2017, most recently in Oct 2022 ($25.5 million sold to 19 investors).
NeuroFlow investors
45 investors are on record for NeuroFlow, including Alumni Ventures, US National Science Foundation, MedTech Innovator and GV. By type, the record holds 13 venture capital firms and 1 growth equity firm. The early-stage round in Jul 2022 drew 19 investors.
About NeuroFlow
Developer of behavioral health integration technology designed to support coordinated care and informed decision-making in healthcare organizations. The company's platform provides cloud-based tools compliant with healthcare privacy regulations for population-level risk identification, remote patient monitoring, structured risk assessment, and care workflow coordination, enabling payors, health systems, and public sector health entities to better understand behavioral health needs and manage care more effectively.
- Sector
- Healthcare
- HQ
- Philadelphia, PA, United States
- Employees
- 200
- Website
- neuroflow.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
NeuroFlow’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.